期刊文献+

利奈唑胺与帕罗西汀合用引起5-羟色胺综合征1例分析 被引量:1

Analysis of a case of serotonin syndrome caused by the combination of linezolid and paroxetine
下载PDF
导出
摘要 目的探讨帕罗西汀与利奈唑胺合用致5-羟色胺综合征的临床特点及临床药师在药源性疾病的鉴别及处置方面发挥的作用。方法临床药师对一例因焦虑症长期口服帕罗西汀的病人,在使用利奈唑胺600 mg,每12小时1次,静脉滴注治疗人葡萄球菌心内膜炎2 d后突发高热、瞻望、震颤及血压飙升等症状进行分析。结果5-羟色胺再摄取抑制剂帕罗西汀与单胺氧化酶抑制剂利奈唑胺合用可导致内源性升压物质拟交感胺类破坏减少,引起5-羟色胺综合征,与病人症状相符。后立即停用两药,同时在监护下进行镇静、降压等对症治疗,最终病人症状纠正。结论在制定临床给药方案时,临床医生应警惕利奈唑胺与5-羟色胺再摄取抑制剂的相互作用,同时重视临床药师在保障用药安全方面发挥的积极作用。 Objective To explore the clinicalfeatures of serotonin syndrome caused by paroxetine andtheroleof clinical pharmacists in identificationand treatment of drug-induced diseases.Methods Clinical pharmacist analyzed the etiology of a series of sudden symptoms such as fever,vision,tremor,and soaring blood pressure ofapatientwhohad been taking orally paroxetine for anxiety neurosis for a long time and received 600 mg of linezolid once every 12 hours,intravenous drip to treat Staphylococcal endocarditis after 2 days.Results The combination of paroxetine asa SSRIs,and linazolamide asa MAOI can lead to a decrease in the destruction of endogenous boost substances,causing serotonin syndrome whichbeingconsistent with the patient’s symptoms.Conclusion In the course of clinical drug therapy,attention should be paid to the adverse drug reactions caused by the interaction of liniazolidomide and SSIRs,and the positive role of clinical pharmacists in ensuring the safety of drug use.
作者 黄雅菲 朱君荣 俞平 HUANG Yafei;ZHU Junrong;YU Ping(Department of Pharmacy,Lishui District People’s Hospital of Nanjing,Jiangsu 211200,China;Department of Pharmacy,the Nanjing First Hospital,Nanjing,Jiangsu 210000,China)
出处 《安徽医药》 CAS 2020年第11期2329-2332,共4页 Anhui Medical and Pharmaceutical Journal
关键词 血清素综合征 帕罗西汀 利奈唑胺 5-羟色胺再摄取抑制剂 药学监护 Serotonin syndrome Paroxetine Lenalidomide SSRIs Pharmaceutical care
  • 相关文献

参考文献3

二级参考文献82

  • 1黄韶清,邱泽武.药物引起的5-羟色胺综合征及其治疗[J].药物不良反应杂志,2004,6(4):243-246. 被引量:11
  • 2许来好.氟西汀所致严重脱发1例报告[J].四川精神卫生,2006,19(4):259-259. 被引量:5
  • 3Nelson LS,Erdman AR,Booze LL.Selective serotonin reuptake inhibitor poisoning:An evidence-based consensus guideline for out-of-hospital management[J].Clin Toxicol (Phila),2007,45:315-332.
  • 4Isbister GK,Bowe SJ,Dawson A,et al.Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose[J].J Toxicol Clin Toxicol,2004,42:277-285.
  • 5Gillman K.A review of serotonin toxicity data:implications for the mechanisms of antidepressant drug action[J].Biol Psychiatry,2006,59:1046-1051.
  • 6Turkel SB,Nadala JG,Wincor MZ.Possible serotonin syndrome in association with 5-HT (3) antagonist agents[J].Psychosomatics,2001,42:258-260.
  • 7Gillman K.Moclobemide and the risk of serotonin toxicity (or serotonin syndrome)[J].CNS Drug Rev,2004,10:83-85.
  • 8Birmes P,Coppin D,Schmitt,L,et al.Serotonin syndrome:a brief review[J].CMAJ,2003,168:1439-1442.
  • 9Boyer EW,Shannon M.The Serotonin Syndrome[J].N Engl J Med,2005,352:1112-1120.
  • 10Gillman K.Monoamine oxidase inhibitors,opioid analgesics and serotonin toxicity[J].Br J Anaesth,2005,95:434-441.

共引文献28

同被引文献10

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部